CITÓMICA
University of Pavia
Pavía, ItaliaUniversity of Pavia-ko ikertzaileekin lankidetzan egindako argitalpenak (10)
2023
-
Definition and Clinical Significance of the Monoclonal Gammopathy of Undetermined Significance-Like Phenotype in Patients With Monoclonal Gammopathies
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 41, Núm. 16, pp. 3019-3031
2022
-
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
Blood, Vol. 140, Núm. 11, pp. 1200-1228
2021
-
Minimal residual disease negativity by next-generation flow cytometry is associated with improved organ response in AL amyloidosis
Blood Cancer Journal, Vol. 11, Núm. 2
2019
-
Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions
Haematologica, Vol. 104, Núm. 10, pp. 1935-1949
2017
-
Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group
Haematologica, Vol. 102, Núm. 2, pp. 308-319
-
Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions
Oncotarget, Vol. 8, Núm. 43, pp. 73483-73500
2014
2013
-
Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: Position paper of an International Consortium and the European LeukemiaNet Working Group
Leukemia and Lymphoma, Vol. 54, Núm. 3, pp. 472-475
2012
-
Standardization of flow cytometry in myelodysplastic syndromes: A report from an international consortium and the European LeukemiaNet Working Group
Leukemia, Vol. 26, Núm. 7, pp. 1730-1741
2009
-
Standardization of flow cytometry in myelodysplastic syndromes: Report from the first European LeukemiaNet working conference on flow cytometry in myelodysplastic syndromes
Haematologica, Vol. 94, Núm. 8, pp. 1124-1134